SEPOY.net
No Result
View All Result
Monday, July 14, 2025
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

Non-traditional gene fusions in luminal breast cancer: A new target for therapy

Nicholas by Nicholas
August 22, 2023
in Health
0
Non-traditional gene fusions in luminal breast cancer: A new target for therapy

A new editorial paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?”

READ ALSO

EAGLE model predicts key lung cancer mutations from routine biopsy

Is fruit juice good or bad for diabetes? New research reveals a genetic twist

A vast majority of breast cancers (~70%) are estrogen receptor-alpha positive (ER+), for which endocrine therapy is the common treatment. However, recurrence often occurs leading to tumor progression, metastasis and eventually patient death, and the underlying molecular mechanisms remain poorly understood. In this new editorial, researchers Chia-Chia Liu and Xiao-Song Wang from the University of Pittsburgh discuss their recent study regarding recurrent gene fusions -; hallmarks of some cancers that resulted either from chromosomal rearrangements or from cis- or trans-splicing.

“Importantly, selected oncogenic fusions have been matched with effective targeted therapy in several solid tumors. For instance, EML4-ALK, one of the most important oncogenic driver genes of non-small cell lung cancer (NSCLC) uncovered in recent years.”

In addition to gene fusions resulting from genomic rearrangements, a read-through SLC45A3-ELK4 fusion transcript has been identified in prostate cancer which is associated with disease progression and metastasis. Although the whole genome and RNA sequencing provide an effective way to detect fusion genes, the downstream identification and validation of fusion genes or their products in solid tumors remains a major challenge. Through analysis of RNA-seq data from TCGA, the authors of this editorial and their co-authors recently identified a neoplastic fusion transcript RAD51AP1-DYRK4 in luminal B breast cancer (~17.5%) showing higher ki67 expression which is an indication of aggressive clinical characteristics.

“In this study, we examined the utility of MEK inhibitor trametinib (Mekinist) currently used for treating melanoma with BRAF mutations, in blocking the MEK-ERK signaling driven by RAD51AP1-DYRK4 fusion. Interestingly […] RAD51AP1-DYRK4 may endow sensitivity to MEK inhibition in luminal B breast cancer. To our knowledge, this is one of the few non-traditional fusions generated by read-through events in the absence of DNA rearrangement that play an important role in tumorigenesis.”

Source:

Journal reference:

Liu, C-C & Wang, X-S., (2023) Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?. Oncotarget. doi.org/10.18632/oncotarget.28438.

Tags: Breast CancerCancerEndocrineEstrogenGeneGenesMEK InhibitorMetastasisOncologyReceptorResearchRNATumor

Related Posts

EAGLE model predicts key lung cancer mutations from routine biopsy
Health

EAGLE model predicts key lung cancer mutations from routine biopsy

July 14, 2025
Is fruit juice good or bad for diabetes? New research reveals a genetic twist
Health

Is fruit juice good or bad for diabetes? New research reveals a genetic twist

July 14, 2025
Underactive thyroid linked to increased risk of small intestinal bacterial overgrowth
Health

Underactive thyroid linked to increased risk of small intestinal bacterial overgrowth

July 12, 2025
Adults over 80 benefit from osteoporosis medications
Health

Adults over 80 benefit from osteoporosis medications

July 12, 2025
OneTouch-PAT system detects breast cancer in under a minute without compression
Health

OneTouch-PAT system detects breast cancer in under a minute without compression

July 12, 2025
Long-term survival achieved in stage III melanoma with pre-surgery immunotherapy
Health

Long-term survival achieved in stage III melanoma with pre-surgery immunotherapy

July 12, 2025
Next Post
Social media and the internet: Top concerns for parents of school-age children

Social media and the internet: Top concerns for parents of school-age children

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: hello@sepoy.net

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • 100% Legal United states Internet poker Bedroom Reviewed
  • Grand Jester Spielautomat Zum Kostenlosen Verbunden Gerieren Comunica DE
  • Senaste Nya Genies Touch spelautomat Casinon

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net